• Explore /
  • Poster
  • / Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.

Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.

Abstract Poster

Authors

null

Hans Gelderblom

Leiden University Medical Center, Leiden, Netherlands

Hans Gelderblom , Mathilde Jalving , Ingrid Desar , Omar Saavedra , Jourik A. Gietema , Stefan van Ravensteijn , Nina Ajmone Marsan , Anne Bellon , Sandrine Micallef , Noemie Luong , Luke Piggott , Rikke Frederiksen Franzen , Esteban Rodrigo Imedio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT03968653

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3012)

DOI

10.1200/JCO.2023.41.16_suppl.3012

Abstract #

3012

Poster Bd #

210

Abstract Disclosures

Similar Posters

First Author: Kyriakos P. Papadopoulos

Poster

2019 ASCO Annual Meeting

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.

First Author: Nancy Chan

First Author: Judy S. Wang

First Author: Nehal J. Lakhani